Acute exacerbations of chronic bronchitis: Pharmacoeconomics

Infections in Medicine

Volumn 16, Issue 3 SUPPL. B, 1999, Pages 41-52

  Grossman, Ronald F ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Acute exacerbations of chronic bronchitis (AECB); Chronic obstructive pulmonary disease (COPD); Fluoroquinolones; Health economics; Pharmacoeconomics; Quality of life

Indexed keywords

EID: 0004644995     PISSN: 07496524     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. American Thoracic Society: Chronic bronchitis, asthma, and pulmonary emphysema: A statement by the Committee on Diagnostic Standards for Nontuberculous Respiratory Diseases. Am Rev Respir Dis 85:762-768, 1962.
2. Ball P, Make BJ: Acute exacerbations of chronic bronchitis: An international comparison. Chest 113(suppl 3):S199-S204, 1998.
3. National Heart, Lung, and Blood Institute: Morbidity and Mortality: 1996 Chartbook on Cardiovascular, Lung, and Blood Diseases. Bethesda, Md., National Institutes of Health, 1996, pp 5-9, 49-53.
4. Lacasse Y, Brooks O, Goldstein RS: Trends in the epidemiology of COPD in Canada. Am J Respir Crit Care Med 157:A764, 1998.
5. Petty TL: A new national strategy for COPD. J Respir Dis 18:365-369, 1997.
6. Lung & Asthma Information Agency: Respiratory Morbidity in General Practice, 1971-1991. London, Department of Health Sciences, St. George's Hospital Medical School, March 1996. Factsheet.
7. Huchon GJ, Gialdroni-Grassi G, Leophonte P, et al: Initial antibiotic therapy for lower respiratory tract infection in the community: A European survey. Eur Respir J 9:1590-1595, 1996.
8. Gonzales R, Steiner JF, Sande MA: Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians. JAMA 278:901-904, 1997.
9. Niederman MS, McCombs JS, Unger AN, et al: The cost of treating acute exacerbations of chronic bronchitis. AmJ Respir Crit Care Med 157:A787, 1998.
10. Leeper KV, Jones AM, Tillotson G: The changing bacterial etiology of chronic obstructive pulmonary disease (COPD). Chest 112(suppl 3S):S21, 1997.
11. Eller J, Ede A, Schaberg T, et al: Infective exacerbations of chronic bronchitis: Relation between bacteriologic etiology and lung function. Chest 113:1542-1548, 1998.
12. Adams S, Melo J, Anzueto A, et al: Effects of antibiotics on the recurrence rates of chronic obstructive pulmonary disease exacerbations. Chest 112(suppl 3S):S22, 1997.
13. Laupacis A, Feeny D, Detoky AS, et al: How attractive does a new technology have to be to warrant adoption and utilization?: Tentative guidelines for using clinical and economic evaluations. Can Med Assoc J 146:473-481, 1992.
14. Freund DA, Dittus RS: Principles of pharmacoeconomic analysis of drug therapy. Pharmacoeconomics 1:20-32, 1992.
15. Jones PW, Quirk FN, Baveystock CM, et al: A self-complete measure for chronic airflow limitation: The St. George's Respiratory Questionnaire. Am Rev Respir Dis 145:1321-1327, 1992.
16. Guyatt GH, Berman LB, Townsend M, et al: A measure of quality of life for clinical trends in chronic lung disease. Thorax 42:773-778, 1987.
17. Grossman R, Mukherjee J, Vaughan D, et al: A 1-year community-based health economic study of ciprofloxacin vs "usual" antibiotic treatment in acute exacerbations of chronic bronchitis. Chest 113:131-141, 1998.